🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr. Alissa Cooper, MD summarizes the state of the art for #SCLC at #NYLung24. Will earlier use of immunotherapy in LS-SCLC change the natural history? Lurbinectedin has been our standard 2L but may move to maintenance. Tarlatamab will have a big impact, though pragmatic barriers.

Benjamin Levy walks us through why lately, ADCs may have over promised but under delivered for our patients with previously-treated mNSCLC #NYLung24

Dr. Anne Chiang at #NYLung24 discusses the current and future use of ctDNA in NSCLC. Worlds of possibilities and already making an impact in the clinic.

A new community is forming at the place with the blue sky! Join the movement and get your #SNO2024 updates there.

Why cancer advocates like me are leaving X by Janet Freeman-Daily statnews.com/2024/11/22/twi… via STAT blue 🦋sky is bustling with new folks

CrozrX Gʀᴇɢᴏʀʏ Rɪᴇʟʏ STAT Cancer can affect anyone regardless of politics. This article contains no political commentary or bias, just a user perspective on declining platform usefulness due to changes in functionality. Your mileage may vary.

In pts with #EGFR #NSCLC, what is the value of continuing osimertinib with platinum-pemetrexed after progression vs stopping osimertinib & switching to platinum pemetrexed? I’m proud to present our multi-center, retrospective, international series published in Everyday Health 🧵

True. Also true, I only consider platinum rechallenge in my practice when CTFI >6 months.

Truly one of the highlights of my career. Honored to have received the award for Outstanding Teacher of the Year 🎉Congratulations to my colleagues who were also recognized! Sylvester Comprehensive Cancer Center Honors Outstanding Faculty Members and Trainees - InventUM news.med.miami.edu/sylvester-hono…

📰 Le Pr Fabrice André lauréat du prix Brinker en recherche clinique pour ses travaux dans le cancer du sein. Chaque année, l’organisation américaine de lutte contre le #cancer du sein Susan G. Komen récompense des médecin-chercheurs pour leurs travaux ayant permis de faire

A new study by Mike V. Gormally, MD PhD, Adam J. Schoenfeld, & team investigated whether HLA genotypes could be determined using information captured through MSK’s next-generation sequencing test MSK-IMPACT®. Learn more ⬇️ Memorial Sloan Kettering Cancer Center mskcc.org/news/msk-resea…

Can't even die in peace

A record 77 new ADCs entered clinical development in 2024 (including those accepted but not yet started). Payload class was clearly dominated by topo1i with 55 ADCs. Greater diversity was observed in antibody targets, featuring novel TAAs and several bispecific ADCs.

Today, Christmas Eve, received a 2,070 page document of SUSARs, as part of role as CI for a trial 😡 Is there anything more pointless? Guaranteed to ensure content, and potentially important information, goes unread How we approach safety data needs a complete reset

The only way you'd spend $27 is by taking a NJ tunnel without EZ Pass. FDNY Firefighters aren't even allowed to live in NJ!

Attempts to enter the Congestion Relief zone with alter/covered fraudulent plates could subject you to arrest and/or fines. These attempts occurred at 2nd Ave & 60th St and 57th St between 9th & 10th Ave.

Predatory Journals — What Can We Do to Protect Their Prey? | New England Journal of Medicine: The number of predatory journals is difficult to accurately determine but was estimated at more than 15,000 in 2021 nejm.org/doi/full/10.10…

New book out, by William Pao. Great stories about developing drugs. Definitely covers EGFR, but other important medicines as well. It is a great read.

Thanks to better treatments, people are living longer after a #lungcancer diagnosis, with many being cured. And close management of those who have had successful treatment is more important than ever. MSK’s Lung Cancer Survivorship Program provides regular screening for

I agree, Breakthrough is a great read for anyone who wishes to understand how new & transformative therapeutics are created and developed